Showing results (461-470 of 471) with videos related to

Sort By:
Pageof 48
American Journal of Preventive Medicine|October 4, 2011
Reuniting public health and medicine: the University of New Mexico School of Medicine Public Health CertificateCynthia M A Geppert, Cynthia L Arndell, Amy Clithero, et al.
JCO Precision Oncology|May 5, 2025
Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer RecurrenceJesus Gonzalez Bosquet, Andrew Polio, Erin George, et al.
Clinical Trials (London, England)|February 26, 2016
Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention TrialThomas M Ramsey, Joni K Snyder, Laura C Lovato, et al.
Research Square|February 6, 2026
Intrinsic tumor factors and extrinsic environmental and social exposures contribute to endometrial cancer recurrence patternsJesus Gonzalez Bosquet, Oyomoare Osazuwa-Peters, Vincent M Wagner, et al.
Neurology|January 17, 2020
Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathiesJoshua J Todd, Tokunbor A Lawal, Jessica W Witherspoon, et al.
Gynecologic Oncology|November 15, 2017
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancerCasey M Cosgrove, David L Tritchler, David E Cohn, et al.
Gynecologic Oncology|January 29, 2023
Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient populationPaulina J Haight, David A Barrington, Stephen M Graves, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort studyAngeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
Gynecologic Oncology Reports|July 7, 2023
Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly populationPaulina J Haight, Rachael N Piver, David A Barrington, et al.
The New England Journal of Medicine|December 6, 2023
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian CancerKathleen N Moore, Antoine Angelergues, Gottfried E Konecny, et al.
Pageof 48